Clinical Trial Update: Efficacy and Safety Study of ME1111 in Patients With Onychomycosis [Phase 2]

View source ↗

Summary

Phase 2 trial results for ME1111 in onychomycosis reported completed with efficacy and safety data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Onychomycosis

Drugs mentioned

• ME1111

Snippet

Sponsor: Meiji Seika Pharma Co., Ltd. | Conditions: Onychomycosis | Phase 2 | Status: COMPLETED